Adding carbimazole to levothyroxine increases triiodothyronine and improves outcome in patients with primary hypothyroidism
A preliminary study from Egypt
Keywords:
The study received no fund or grant.Abstract
Background: Many hypothyroid patients are not tolerant and not satisfied with levothyroxine (LT4). Older studies used large doses of both carbimazole and LT4 for Hashimoto’s thyroiditis (HT), because Graves’ disease (GD) and HT were considered as very closely related syndromes produced by thyroid autoimmunity.
Objective: The aim of the study was to determine the outcome after adding small doses of carbimazole to reduced doses of LT4 for patients with primary hypothyroidism, who are unable to tolerate LT4.
Methods: The study is a non-randomized, single arm, interventional study. It included 19 female patients diagnosed with primary hypothyroidism who could not tolerate LT4. Subjects were recruited from the outpatient clinic of AL-Azhar University Hospital in Damietta, Egypt from January to March 2015. They were divided into two groups; group 1 included 10 patients with HT and 2 patients with non-specified primary hypothyroidism, and group 2 included 7 patients with subtotal thyroidectomy for GD. All patients received carbimazole (10 mg/day) beside LT4 (25 μg thrice/week) for 10 weeks. Statistical analysis of the data was done by SPSS version 20, using paired-sample t-test, ANOVA, Chi square, and Pearson coefficient test.
Results: There was significant increase in free triiodothyronine (FT3) in addition to significant improvement in depression and LT4 tolerance in the whole population. There was non-significant improvement in TSH in group 1 (p=0.053). Surprisingly, in group 2, in spite of significant increase in TSH (p=0.007) and non-significant decrease in free thyroxine (FT4), there was non-significant increase in FT3. Whether carbimazole improves the pathology of the hypothyroid gland or the peripheral deiodination of T4 to T3 (where the serum and tissue levels of the latter may be responsible for improvement of symptoms) is in need of investigation.
Conclusions: Adding carbimazole to LT4 improves FT3, LT4 tolerance, and depression in primary hypothyroid female patients. Further studies are required to determine the appropriate doses of this regimen in different cases.
Clinical trial registration: This study was registered at Thai Clinical Trials Registration center (http://www.clinicaltrials.in.th) with registration ID: TCTR20170123003.
References
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of
hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement.
Thyroid. 2014; 24(12): 1670-751. doi: 10.1089/thy.2014.0028. PMID: 25266247, PMCID: PMC4267409.
Dayan CM, Panicker V. Hypothyroidism and Depression. Eur Thyroid J. 2013; 2: 168–79. doi:
1159/000353777. PMID: 24847450, PMCID: PMC4017747.
Bianchi GP, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M, et al. Health-related quality of life in
patients with thyroid disorders. Qual Life Res. 2004; 13: 45–54. doi:
1023/B:QURE.0000015315.35184.66. PMID: 15058786.
Abraham P, Acharya S. Current and emerging treatment options for Graves' hyperthyroidism. Ther Clin
Risk Manag. 2010; 6: 29-40. PMID: 20169034, PMCID: PMC2817786.
Akamizu T, Amino N, DeGroot LJ: Hashimoto’s Thyroiditis. In: De Groot LJ, Beck-Peccoz P, Chrousos
G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A,
Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2013 Dec 20.
Dasari S, Naha K, Hande M, Vivek G. Hot and cold: coexistent Graves' disease and Hashimoto's thyroiditis
in a patient with Schmidt's syndrome. BMJ Case Rep. 2014; 2014. doi: 10.1136/bcr-2013-010432. PMID:
, PMCID: PMC4039812.
McGregor AM, Ibbertson HK, Smith BR, Hall R. Carbimazole and autoantibodv synthesis in Hashimoto's
thyroiditis. BMJ. 1980; 281(6246): 968-9. doi: 10.1136/bmj.281.6246.968. PMID: 6893563, PMCID:
PMC1714378.
Rennie DP, McGregor AM, Keast D, Weetman AP, Foord SM, Dieguez C, et al. The influence of
methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology. 1983; 112(1):
-30. doi: 10.1210/endo-112-1-326. PMID: 6847827.
Fernandez ME, Lopez SM, Cazaux A, Cambursano VH, Cortes JR. Insomnia: prevalence in Cordopa city
hospital. Rev Fac Cien Med Univ Nac Cordoba. 2012; 69(4): 191-6. PMID: 23751785.
Valizadeh M, Seyyed-Majidi MR, Hajibeigloo H, Momtazi S, Musavinasab N, Hayatbakhsh MR. Efficacy
of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary
hypothyroidism: a randomized controlled trial. Endocr Res. 2009; 34: 80–9. doi:
1080/07435800903156340. PMID: 19701833.
Brown LK, Dedrick DL, Doggett JW, Guido PS. Antidepressant medication use and restless legs syndrome
in patients presenting with insomnia. Sleep Med. 2005; 6(5): 443-50. doi: 10.1016/j.sleep.2005.03.005.
PMID: 16084763.
Takasu N, Yamada T, Takasu M, Komiya I, Nagasawa Y, Asawa T. Disappearance of thyrotropin-blocking
antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis. N Engl J Med. 1992;
(8): 513-8. doi: 10.1056/NEJM199202203260803. PMID: 1732791.
Jansson R, Karlsson A, Forsum U. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in
Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol. 1984; 58(2):
-72. PMID: 6238731, PMCID: PMC1577052.
Jansson R, Karlsson A, Dahlberg PA. Thyroxine, methimazole, and thyroid microsomal autoantibody titres
in hypothyroid Hashimoto's thyroiditis. BMJ (Clin Res Ed). 1985; 290(6461): 11-2. doi:
1136/bmj.290.6461.11. PMID: 3917315, PMCID: PMC1415424.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry.
; 134: 382-9. doi: 10.1192/bjp.134.4.382. PMID: 444788.
Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012; 122: 3035–43. doi:
1172/JCI60047. PMID: 22945636, PMCID: PMC3433956.
Thvilum M, Brandt F, Brix TH, Hegedus L. A review of the evidence for and against increased mortality in
hypothyroidism. Nat Rev Endocrinol. 2012; 8(7): 417–24. doi: 10.1038/nrendo.2012.29. PMID: 22392154.
Braverman LE, Ingbar SH, Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic
human subjects. J Clin Invest. 1970; 49(5): 855–64. doi: 10.1172/JCI106304. PMID: 4986007, PMCID:
PMC535757.
Escobar-Morreale HF, Obregón MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for
hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in
thyroidectomized rats. J Clin Invest. 1995; 96(6): 2828-38. doi: 10.1172/JCI118353. PMID: 8675653,
PMCID: PMC185993.
Iverson JF, Mariash CN. Optimal free thyroxine levels for thyroid hormone replacement in
hypothyroidism. Endocr Pract. 2008; 14(5): 550–5. doi: 10.4158/EP.14.5.550. PMID: 18753096.
Jonklaas J, Davidson B, Bhagat S, Soldin SJ. Triiodothyronine levels in athyreotic individuals during
levothyroxine therapy. JAMA. 2008; 299(7): 769–77. doi: 10.1001/jama.299.7.769. PMID: 18285588.
Woeber KA. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J
Endocrinol Invest. 2002; 25(2): 106–9. doi: 10.1007/BF03343972. PMID: 11929079.
Ito M, Miyauchi A, Morita S, Kudo T, Nishihara E, Kihara M, et al. TSH-suppressive doses of
levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who
have undergone total thyroidectomy. Eur J Endocrinol. 2012; 167(3): 373–8. doi: 10.1530/EJE-11-1029.
PMID: 22711760.
Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM. Common variation
in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus
triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009; 94(5): 1623–9. doi:
1210/jc.2008-1301. PMID: 19190113.
Ma C, Xie J, Huang X, Wang G, Wang Y, Wang X, et al. Thyroxine alone or thyroxine plus
triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun. 2009; 30(8): 586-93.
PMID: 19491714.
Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, et al. Combined thyroxine/liothyronine
treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a
randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003;
(10):4543–50. doi: 10.1210/jc.2003-030249. PMID: 14557419.
Geffner DL, Azukizawa M, Hershman JM. Propylthiouracil blocks extrathyroidal conversion of thyroxine
to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest. 1975; 55(2): 224–9. doi:
1172/JCI107925. PMID: 805160, PMCID: PMC301740.
Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology,
and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002; 23(1): 38–89. doi:
1210/edrv.23.1.0455. PMID: 11844744.
van der Deure WM, Appelhof BC, Peeters RP, Wiersinga WM, Wekking EM, Huyser J, et al.
Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and
depression in hypothyroid patients. Clin Endocrinol. 2008; 69(5): 804–11. doi: 10.1111/j.1365- 2265.2008.03267.x. PMID: 18410547.
Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. Levothyroxine monotherapy cannot
guarantee euthyroidism in all athyreotic patients. PLoS One. 2011; 6(8): e22552. doi:
1371/journal.pone.0022552. PMID: 21829633, PMCID: PMC3148220.
Alevizaki M, Mantzou E, Cimponeriu AT, Alevizaki CC, Koutras DA. TSH may not be a good marker for
adequate thyroid hormone replacement therapy. Wien Klin Wochenschr. 2005; 117(18): 636–40. doi:
1007/s00508-005-0421-0. PMID: 16416346.
Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, et al. The link between thyroid
autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community:
a field of interest for public health in the future. BMC Psychiatry. 2004; 4: 25. doi: 10.1186/1471-244X-4- 25. PMID: 15317653, PMCID: PMC516779.
Padberg S, Heller K, Usadel KH, Schumm-Draeger PM. One-year prophylactic treatment of euthyroid
hashimoto’s thyroiditis patients with levothyroxine: Is there a benefit? Thyroid. 2001; 11(3): 249-55. doi:
1089/105072501750159651. PMID: 11327616.
Engum A, Bjoro T, Mykletun A, Dahl AA. Thyroid autoimmunity, depression and anxiety; are there any
connections? An epidemiological study of a large population. J Psychosom Res. 2005; 59(5): 263–8. doi:
1016/j.jpsychores.2005.04.002. PMID: 16253615.
Balazs C, Kiss E, Leövey A, Farid NR. The immunosuppressive effect of methimazole on cell-mediated
immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clin
Endocrinol (Oxf). 1986; 25(1): 7-16. doi: 10.1111/j.1365-2265.1986.tb03590.x. PMID: 3024872.
Tomer Y. Mechanisms of Autoimmune Thyroid Diseases: From Genetics to Epigenetics. Annu Rev Pathol.
; 9: 147–56. doi: 10.1146/annurev-pathol-012513-104713. PMID: 24460189, PMCID: PMC4128637.
Umar H, Muallima N, Adam JM, Sanusi H. Hashimoto's thyroiditis following Graves' disease. Acta Med
Indones. 2010; 42(1): 31-5. PMID: 20305330.
Aşık M, Binnetoğlu E, Şen H, Tekeli Z, Uysal F, Ukinç K. Graves’ disease associated with Alopecia areata
developed after Hashimoto's thyroiditis. Endocrine Abstracts. 2013; 32: 309. doi:
1530/endoabs.32.P309.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
